---
title: "Jiangxi Sanxin Medtec Co.,Ltd. (300453.SZ)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/300453.SZ.md"
symbol: "300453.SZ"
name: "Jiangxi Sanxin Medtec Co.,Ltd."
industry: "Health Care Supplies"
datetime: "2026-05-19T20:26:12.134Z"
locales:
  - [en](https://longbridge.com/en/quote/300453.SZ.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/300453.SZ.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/300453.SZ.md)
---

# Jiangxi Sanxin Medtec Co.,Ltd. (300453.SZ)

## Company Overview

Jiangxi Sanxin Medtec Co.,Ltd. engages in the research and development, manufacture, sale, and service of medical devices. The company offers infusion and cardiothoracic surgery products; and blood purification products, such as dialysate filter, dialysis indwelling needle, disposable biological protein glue dispenser, dialysis fluid filter, continuous blood purification pipeline and accessories, hemodialysis concentrate, hemodialysis water production systems, hemodialysis machines, centralized liquid supply system, dialysis care package, central venous catheter kits, arteriovenous spikes, accessories tubing for HDF, dialysate filters, hemodialysis dry powders and concentrates, disposable hollow fiber dialyzers, blood purification and fluid replacement pipeline, and hemodialysis tubing. It also provides pre filled catheter flushing device, heparin cap, sterile needle, disposable filtration infusion set, disposable light shielded precision filtration infusion set, blood transfusion device, infusion disinfection connector, Y-shaped indwelling needle, closed vein indwelling needle, pneumatic needle free injector, insulin syringe, injection needle, dispensing syringe, disposable sterile syringe, fixed dose vaccine injector, extension tube, positive pressure venous indwelling needle, and self-destructible syringe.

| Item | Detail |
|------|--------|
| Industry | Health Care Supplies |
| Exchange | CN Market |
| Website | [www.sanxin-med.com](https://www.sanxin-med.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: B
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-19T04:30:08.000Z

**Overall: B (0.30)**

**Industry**: Health Care Supplies

| Metric | Value |
|--------|-------|
| Industry Ranking | 9 / 40 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: B

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 10.37% |  |
| Net Profit YoY | 22.88% |  |
| P/B Ratio | 3.33 |  |
| Dividend Ratio | 1.02% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 5090676722.18 |  |
| Revenue | 1686875501.32 |  |

#### Multi Score Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 19.20% | A |
| Profit Margin | 16.56% | A |
| Gross Margin | 37.11% | B |
| Revenue YoY | 10.37% | B |
| Net Profit YoY | 22.88% | B |
| Total Assets YoY | 9.74% | B |
| Net Assets YoY | 9.87% | B |
| Cash Flow Margin | 148.99% | B |
| OCF YoY | 10.37% | B |
| Turnover | 0.72 | B |
| Gearing Ratio | 33.76% | B |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Jiangxi Sanxin Medtec Co.,Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "10.37%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "22.88%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "3.33",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "1.02%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "5090676722.18",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "1686875501.32",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "19.20%",
          "rating": "A"
        },
        {
          "name": "Profit Margin",
          "value": "16.56%",
          "rating": "A"
        },
        {
          "name": "Gross Margin",
          "value": "37.11%",
          "rating": "B"
        },
        {
          "name": "Revenue YoY",
          "value": "10.37%",
          "rating": "B"
        },
        {
          "name": "Net Profit YoY",
          "value": "22.88%",
          "rating": "B"
        },
        {
          "name": "Total Assets YoY",
          "value": "9.74%",
          "rating": "B"
        },
        {
          "name": "Net Assets YoY",
          "value": "9.87%",
          "rating": "B"
        },
        {
          "name": "Cash Flow Margin",
          "value": "148.99%",
          "rating": "B"
        },
        {
          "name": "OCF YoY",
          "value": "10.37%",
          "rating": "B"
        },
        {
          "name": "Turnover",
          "value": "0.72",
          "rating": "B"
        },
        {
          "name": "Gearing Ratio",
          "value": "33.76%",
          "rating": "B"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 18.43 | 3/40 | 20.95 | 20.05 | 19.01 |
| PB | 3.37 | 31/40 | 3.71 | 3.53 | 3.30 |
| PS (TTM) | 3.05 | 8/40 | 3.22 | 3.06 | 2.89 |
| Dividend Yield | 1.01% | 22/40 | 3.44% | 3.23% | 3.04% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Snibe (300832.SZ) | A | D | C | A | C | B |
| 02 | Winner Medical (300888.SZ) | B | B | B | B | B | B |
| 03 | Fuerjia (301371.SZ) | B | C | D | A | B | B |
| 04 | MTM (688029.SH) | B | B | B | A | B | B |
| 05 | Endovastec (688016.SH) | A | B | D | A | B | B |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/300453.SZ/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/300453.SZ/norm.md)
- [Related News](https://longbridge.com/en/quote/300453.SZ/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/300453.SZ/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**